Literature DB >> 33166473

Episodic Aspiration with Oral Commensals Induces a MyD88-dependent, Pulmonary T-Helper Cell Type 17 Response that Mitigates Susceptibility to Streptococcus pneumoniae.

Benjamin G Wu1,2,3, Imran Sulaiman1,2, Jun-Chieh J Tsay1,2,3, Luisanny Perez1,2, Brendan Franca1,2, Yonghua Li1,2, Jing Wang1,4, Amber N Gonzalez1,2, Mariam El-Ashmawy2, Joseph Carpenito1,2, Evan Olsen1,2, Maya Sauthoff1,2, Kevin Yie1,2, Xiuxiu Liu5, Nan Shen6, Jose C Clemente6, Bianca Kapoor2, Tonia Zangari7, Valeria Mezzano8,9, Cynthia Loomis8,10, Michael D Weiden1,2, Sergei B Koralov10, Jeanine D'Armiento11, Sunil K Ahuja12, Xue-Ru Wu10,13, Jeffrey N Weiser7, Leopoldo N Segal1,2.   

Abstract

Rationale: Cross-sectional human data suggest that enrichment of oral anaerobic bacteria in the lung is associated with an increased T-helper cell type 17 (Th17) inflammatory phenotype.
Objectives: In this study, we evaluated the microbial and host immune-response dynamics after aspiration with oral commensals using a preclinical mouse model.
Methods: Aspiration with a mixture of human oral commensals (MOC; Prevotella melaninogenica, Veillonella parvula, and Streptococcus mitis) was modeled in mice followed by variable time of killing. The genetic backgrounds of mice included wild-type, MyD88-knockout, and STAT3C backgrounds.Measurements and Main
Results: 16S-rRNA gene sequencing characterized changes in microbiota. Flow cytometry, cytokine measurement via Luminex and RNA host-transcriptome sequencing was used to characterize the host immune phenotype. Although MOC aspiration correlated with lower-airway dysbiosis that resolved within 5 days, it induced an extended inflammatory response associated with IL-17-producing T cells lasting at least 14 days. MyD88 expression was required for the IL-17 response to MOC aspiration, but not for T-cell activation or IFN-γ expression. MOC aspiration before a respiratory challenge with S. pneumoniae led to a decrease in hosts' susceptibility to this pathogen.Conclusions: Thus, in otherwise healthy mice, a single aspiration event with oral commensals is rapidly cleared from the lower airways but induces a prolonged Th17 response that secondarily decreases susceptibility to S. pneumoniae. Translationally, these data implicate an immunoprotective role of episodic microaspiration of oral microbes in the regulation of the lung immune phenotype and mitigation of host susceptibility to infection with lower-airway pathogens.

Entities:  

Keywords:  inflammation; microbiome; pathogen susceptibility; transcriptomics

Mesh:

Substances:

Year:  2021        PMID: 33166473      PMCID: PMC8314894          DOI: 10.1164/rccm.202005-1596OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  50 in total

1.  Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation.

Authors:  Yoshiyuki Goto; Casandra Panea; Gaku Nakato; Anna Cebula; Carolyn Lee; Marta Galan Diez; Terri M Laufer; Leszek Ignatowicz; Ivaylo I Ivanov
Journal:  Immunity       Date:  2014-03-27       Impact factor: 31.745

2.  Airway Microbiota Determines Innate Cell Inflammatory or Tissue Remodeling Profiles in Lung Transplantation.

Authors:  Eric Bernasconi; Céline Pattaroni; Angela Koutsokera; Christophe Pison; Romain Kessler; Christian Benden; Paola M Soccal; Antoine Magnan; John-David Aubert; Benjamin J Marsland; Laurent P Nicod
Journal:  Am J Respir Crit Care Med       Date:  2016-11-15       Impact factor: 21.405

3.  Induction of colonic regulatory T cells by indigenous Clostridium species.

Authors:  Koji Atarashi; Takeshi Tanoue; Tatsuichiro Shima; Akemi Imaoka; Tomomi Kuwahara; Yoshika Momose; Genhong Cheng; Sho Yamasaki; Takashi Saito; Yusuke Ohba; Tadatsugu Taniguchi; Kiyoshi Takeda; Shohei Hori; Ivaylo I Ivanov; Yoshinori Umesaki; Kikuji Itoh; Kenya Honda
Journal:  Science       Date:  2010-12-23       Impact factor: 47.728

4.  Of Mice and Men . . . and Microbes: Conclusions and Cautions from a Murine Study of the Lung Microbiome and Microbiome-Immune Interactions.

Authors:  John E McGinniss; Ronald G Collman
Journal:  Am J Respir Crit Care Med       Date:  2018-08-15       Impact factor: 21.405

5.  Analysis of the lung microbiome in the "healthy" smoker and in COPD.

Authors:  John R Erb-Downward; Deborah L Thompson; Meilan K Han; Christine M Freeman; Lisa McCloskey; Lindsay A Schmidt; Vincent B Young; Galen B Toews; Jeffrey L Curtis; Baskaran Sundaram; Fernando J Martinez; Gary B Huffnagle
Journal:  PLoS One       Date:  2011-02-22       Impact factor: 3.240

6.  Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals.

Authors:  Christine M Bassis; John R Erb-Downward; Robert P Dickson; Christine M Freeman; Thomas M Schmidt; Vincent B Young; James M Beck; Jeffrey L Curtis; Gary B Huffnagle
Journal:  MBio       Date:  2015-03-03       Impact factor: 7.867

7.  Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung.

Authors:  Leopoldo N Segal; Jose C Clemente; Benjamin G Wu; William R Wikoff; Zhan Gao; Yonghua Li; Jane P Ko; William N Rom; Martin J Blaser; Michael D Weiden
Journal:  Thorax       Date:  2016-08-02       Impact factor: 9.139

8.  Transcriptionally Active Lung Microbiome and Its Association with Bacterial Biomass and Host Inflammatory Status.

Authors:  Lili Ren; Rongbao Zhang; Jian Rao; Yan Xiao; Zhao Zhang; Bin Yang; Depan Cao; Hui Zhong; Pu Ning; Ying Shang; Mingkun Li; Zhancheng Gao; Jianwei Wang
Journal:  mSystems       Date:  2018-10-30       Impact factor: 6.496

9.  The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote.

Authors:  Yang Liao; Gordon K Smyth; Wei Shi
Journal:  Nucleic Acids Res       Date:  2013-04-04       Impact factor: 16.971

10.  The murine lung microbiome in relation to the intestinal and vaginal bacterial communities.

Authors:  Kenneth Klingenberg Barfod; Michael Roggenbuck; Lars Hestbjerg Hansen; Susanne Schjørring; Søren Thor Larsen; Søren Johannes Sørensen; Karen Angeliki Krogfelt
Journal:  BMC Microbiol       Date:  2013-12-28       Impact factor: 3.605

View more
  14 in total

1.  Multi-omics analyses of airway host-microbe interactions in chronic obstructive pulmonary disease identify potential therapeutic interventions.

Authors:  Zhengzheng Yan; Boxuan Chen; Yuqiong Yang; Xinzhu Yi; Mingyuan Wei; Gertrude Ecklu-Mensah; Mary M Buschmann; Haiyue Liu; Jingyuan Gao; Weijie Liang; Xiaomin Liu; Junhao Yang; Wei Ma; Zhenyu Liang; Fengyan Wang; Dandan Chen; Lingwei Wang; Weijuan Shi; Martin R Stampfli; Pan Li; Shenhai Gong; Xia Chen; Wensheng Shu; Emad M El-Omar; Jack A Gilbert; Martin J Blaser; Hongwei Zhou; Rongchang Chen; Zhang Wang
Journal:  Nat Microbiol       Date:  2022-08-22       Impact factor: 30.964

2.  Transcriptome and metabolome analyses reveal the interweaving of immune response and metabolic regulation in pelvic organ prolapse.

Authors:  Xia Yu; Ying Chen; Li He; Hong Liu; Zhenglin Yang; Yonghong Lin
Journal:  Int Urogynecol J       Date:  2022-09-22       Impact factor: 1.932

3.  Whole lung tissue is the preferred sampling method for amplicon-based characterization of murine lung microbiota.

Authors:  Jennifer M Baker; Kevin J Hinkle; Roderick A McDonald; Christopher A Brown; Nicole R Falkowski; Gary B Huffnagle; Robert P Dickson
Journal:  Microbiome       Date:  2021-05-05       Impact factor: 14.650

4.  Selective Modulation of the Pulmonary Innate Immune Response Does Not Change Lung Microbiota in Healthy Mice.

Authors:  Jezreel Pantaleón García; Kevin J Hinkle; Nicole R Falkowski; Scott E Evans; Robert P Dickson
Journal:  Am J Respir Crit Care Med       Date:  2021-09-15       Impact factor: 30.528

Review 5.  The lung microbiome: progress and promise.

Authors:  Samantha A Whiteside; John E McGinniss; Ronald G Collman
Journal:  J Clin Invest       Date:  2021-08-02       Impact factor: 19.456

6.  Reply to Yasuma et al.: Response of Lung Microbiota to Changes of Pulmonary Innate Immunity under Healthy Conditions.

Authors:  Jezreel Pantaleón García; Kevin J Hinkle; Nicole R Falkowski; Scott E Evans; Robert P Dickson
Journal:  Am J Respir Crit Care Med       Date:  2022-02-15       Impact factor: 30.528

Review 7.  Targeting the Pulmonary Microbiota to Fight against Respiratory Diseases.

Authors:  Zongjie Li; Yuhao Li; Qing Sun; Jianchao Wei; Beibei Li; Yafeng Qiu; Ke Liu; Donghua Shao; Zhiyong Ma
Journal:  Cells       Date:  2022-03-07       Impact factor: 6.600

8.  Toll-like receptors, environmental caging, and lung dysbiosis.

Authors:  Jay H Lipinski; Nicole R Falkowski; Gary B Huffnagle; John R Erb-Downward; Robert P Dickson; Beth B Moore; David N O'Dwyer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-06-23       Impact factor: 6.011

Review 9.  Oral Prevotella Species and Their Connection to Events of Clinical Relevance in Gastrointestinal and Respiratory Tracts.

Authors:  Eija Könönen; Ulvi K Gursoy
Journal:  Front Microbiol       Date:  2022-01-06       Impact factor: 5.640

Review 10.  Systems Biology and Bile Acid Signalling in Microbiome-Host Interactions in the Cystic Fibrosis Lung.

Authors:  David F Woods; Stephanie Flynn; Jose A Caparrós-Martín; Stephen M Stick; F Jerry Reen; Fergal O'Gara
Journal:  Antibiotics (Basel)       Date:  2021-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.